Skip to main content

The New Profile of Drug-Resistant Tuberculosis in Russia A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science (2011) / Chapter Skim
Currently Skimming:

Appendix A: Agenda
Pages 113-120

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 113...
... The implications of totally drug resistant (TDR) tuberculosis will also be discussed, as well as the newly emerging profile of MDR TB.
Read the entire page →
From page 114...
... Krasnoproletarskaya ulitsa, 32-34 127473 Moscow, Russia 09:00–09:30 Welcoming Remarks and Overview of Conference Objectives Dmitry Orlov, Russian Academy of Medical Sciences Mikhail Perelman, Moscow Medical Academy Gail Cassell, Eli Lilly and Company 09:30–12:30 Roundtable #1: Magnitude of the Burden of Drug Resistant Tuberculosis -- Local and Global Perspectives Co-Chairs: Marina Yakimova, Central TB Research Institute Jeffrey Drazen, New England Journal of Medicine Global Status of MDR/XTR Tuberculosis, 30 min Salmaan Keshavjee, Chair, Green Light Committee (GLC) Harvard Medical School Epidemiology of TB in the Russian Federation, 30 min Marina Yakimova, Central TB Research Institute Prevalence of Drug Resistance at the Initiation of Second Line Drugs in Eight Countries, 30 min Peter Cegielski, U.S.
Read the entire page →
From page 115...
... 115 APPENDIX A Current Status of Disease Burden and Programmatic Management of MDR/XDR TB in China, 30 min Mingting Chen, Center for Disease Control and Pre vention, China Roundtable Discussion, 30 min 12:30–13:30 Lunch 13:30–15:30 Roundtable #2: The Capability of Health Care Systems to Keep Up with the Spread of MDR TB Co-Chairs: Elena Skachkova, Central Research Institute for the Organization and Informatization of Health Care, Moscow Dale Nordenberg, Novasano Health and Science Monitoring System of MDR TB, 30 min Elena Skachkova, Central Research Institute for the Organization and Informatization of Health Care, Moscow Surveillance Systems for TB Drug Resistance in China, 30 min Renzhong Li, Center for Disease Control and Prevention, China Laboratory lnformation Barriers to MDR TB Control, 30 min Dale Nordenberg, Novasano Health and Science Roundtable Discussion, 30 min 15:30 – 15:45 Break 15:45 – 17:45 Roundtable #3: Treatment of Drug-Resistant TB in Vulnerable Patient Populations Co-Chairs: Irina Vasilyeva, Central TB Research Institute Janet Tobias, Ikana Media Treatment of MDR TB, the CTRI Experience, 15 min Irina Vasilyeva, Central TB Research Institute
Read the entire page →
From page 116...
... Barbara Laughon, NIAID/NIH Alexandr Apt, Central Institute for Tuberculosis, Moscow Opportunities for International Cooperation Stuart Politi, Civilian Research and Development Foundation 1 Unable to attend the workshop due to an emergency.
Read the entire page →
From page 117...
... 117 APPENDIX A Thursday, May 27 Conference Venue: International Science & Technology Centre (ISTC) Krasnoproletarskaya ulitsa, 32-34 127473 Moscow, Russia 08:30–10:10 Roundtable #4: Rapid Methods for Determining Drug Resistance in Tuberculosis and Implications for Patient Management Co-Chairs: Elena Larionova, Central TB Research Institute Jerrold Ellner, Division of Infectious Diseases, Boston University Molecular and Genetic Methods of Mycobacteria Identification in Russia, 20 min Tatiana Smirnova, Central TB Research Institute Overview of Rapid Methods for Determining Drug Resistance in Mycobacterium tuberculosis, 20 min Elena Larionova, Central TB Research Institute Implication of Rapid Detection of Resistance in Patient Management, 20 min Danila Zimenkov, Engelhardt lnstitute of Molecular Biology, Moscow Response Panel and Roundtable Discussion, 40 min Maria Giovanni, National Institute of Allergy and Infectious Diseases, National Institutes of Health Nico Gey van Pittius, Stellenbosch University, South Africa Qian Gao, Shanghai Medical College, China 10:10–12:00 Roundtable #5: MDR TB Transmission and Infection Control Co-Chairs: Rostislav Mitrofanov, Novosibirsk Tuberculosis Research Institute Edward Nardell, Harvard Medical School Infection Control in Anti-Tuberculosis Institutions, 20 min Elina Sevastyanova, Central TB Research Institute
Read the entire page →
From page 118...
... Mark Maeurer, Karolinska Institute Roundtable Discussion, 10 min 13:50–14:35 Roundtable #7: Addressing Challenges in MDR TB Drug Procurement Co-chairs: Nikita Afanasiev, USAID, Moscow Paul Zintl, Partners In Health The World Health Assembly Resolution on MDR/XDR TB: Is It Important for Russia's Second-Line TB Drug Supply? 15 min Paul Zintl, Partners In Health
Read the entire page →
From page 119...
... Centers for Disease Control and Prevention Mingting Chen, Center for Disease Control and Prevention, China Gerrit Coetzee, National Health Laboratory Service, South Africa Janet Tobias, Ikana Media 18:15–18:30 Closing Remarks Gail Cassell, Eli Lilly and Company
Read the entire page →

Key Terms

  • response panel
  • south africa
  • drug resistant
  • light committee
  • mingting chen

  • green light
  • salmaan keshavjee
  • gail cassell
  • eli lilly
  • marina yakimova

  • russian academy
  • medical sciences
  • infection control
  • drug resistance
  • mikhail perelman

  • dmitry orlov
  • totally drug
  • gerrit coetzee
  • health laboratory
  • health commissioner

  • newly emerging
  • jeffrey drazen
  • addressing challenges
  • extensively drug
  • emerging profile

  • laboratory service
  • moscow medical
  • medical academy
  • health assembly
  • africa based


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.